Cargando…

Correction: Behavioral Phenotyping of Parkin-Deficient Mice: Looking for Early Preclinical Features of Parkinson's Disease

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351000/ https://www.ncbi.nlm.nih.gov/pubmed/25742613 http://dx.doi.org/10.1371/journal.pone.0118526

Ejemplares similares

Behavioral Phenotyping of Parkin-Deficient Mice: Looking for Early Preclinical Features of Parkinson's Disease
por: Rial, Daniel, et al.
Publicado: (2014)

Correction: Behavioral and Neurotransmitter Abnormalities in Mice Deficient for Parkin, DJ-1 and Superoxide Dismutase
Publicado: (2014)

Correction: Cell-Permeable Parkin Proteins Suppress Parkinson Disease-Associated Phenotypes in Cultured Cells and Animals
Publicado: (2014)

Correction to: Parkin regulates neuronal lipid homeostasis through SREBP2-lipoprotein lipase pathway—implications for Parkinson's disease
Publicado: (2023)

Correction: The Skeletal Phenotype of Chondroadherin Deficient Mice
por: Hessle, Lovisa, et al.
Publicado: (2013)

Correction: Superoxide drives progression of Parkin/PINK1-dependent mitophagy following translocation of Parkin to mitochondria
por: Xiao, Bin, et al.
Publicado: (2018)

Parkinson's disease relevant pathological features are manifested in male Pink1/Parkin deficient rats
por: Lamberty, Benjamin G., et al.
Publicado: (2023)

Behavioral and Neurotransmitter Abnormalities in Mice Deficient for Parkin, DJ-1 and Superoxide Dismutase
por: Hennis, Meghan R., et al.
Publicado: (2013)

Author Correction: Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson’s disease phenotypes
por: Riboldi, Giulietta Maria, et al.
Publicado: (2023)

Correction: Parkin-mediated mitophagy as a potential therapeutic target for intervertebral disc degeneration
por: Zhang, Zengjie, et al.
Publicado: (2021)

The Roles of PINK1 and Parkin in Parkinson's Disease
por: Jones, Rachel
Publicado: (2010)

Parkin beyond Parkinson’s Disease—A Functional Meaning of Parkin Downregulation in TDP-43 Proteinopathies
por: Gaweda-Walerych, Katarzyna, et al.
Publicado: (2021)

AF-6 is a positive modulator of the PINK1/parkin pathway and is deficient in Parkinson's disease
por: Haskin, Joseph, et al.
Publicado: (2013)

Counteracting PINK/Parkin Deficiency in the Activation of Mitophagy: A Potential Therapeutic Intervention for Parkinson’s Disease
por: Nardin, Alice, et al.
Publicado: (2016)

Publisher Correction: Parkin-dependent regulation of the MCU complex component MICU1
por: Matteucci, Alessandra, et al.
Publicado: (2019)

Cell-Permeable Parkin Proteins Suppress Parkinson Disease-Associated Phenotypes in Cultured Cells and Animals
por: Duong, Tam, et al.
Publicado: (2014)

Tissue- and Cell-Specific Mitochondrial Defect in Parkin-Deficient Mice
por: Damiano, Maria, et al.
Publicado: (2014)

Parkin contributes to synaptic vesicle autophagy in Bassoon-deficient mice
por: Hoffmann-Conaway, Sheila, et al.
Publicado: (2020)

Chronic overload of SEPT4, a parkin substrate that aggregates in Parkinson’s disease, causes behavioral alterations but not neurodegeneration in mice
por: Ageta-Ishihara, Natsumi, et al.
Publicado: (2013)

Mitophagy and Parkinson's disease: The PINK1–parkin link()
por: Deas, Emma, et al.
Publicado: (2011)

Will Crystal Parkin Help in Understanding the Future of Parkinson’s Disease?
por: Olszewska, Diana Angelika, et al.
Publicado: (2015)

Olfaction in Parkin carriers in Chinese patients with Parkinson disease
por: Wang, Ying, et al.
Publicado: (2017)

Parkin (PARK 2) Mutations Are Rare in Czech Patients with Early-Onset Parkinson's Disease
por: Fiala, Ondrej, et al.
Publicado: (2014)

Early Dyskinesias in Parkinson’s Disease Patients With Parkin Mutation: A Primary Corticostriatal Synaptopathy?
por: Sassone, Jenny, et al.
Publicado: (2019)

Correction: Driver Gaze Behavior Is Different in Normal Curve Driving and when Looking at the Tangent Point
Publicado: (2015)

Correction: The Neurotoxicity of DOPAL: Behavioral and Stereological Evidence for Its Role in Parkinson Disease Pathogenesis
por: Panneton, W. Michael, et al.
Publicado: (2011)

Correction: Redistribution of DAT/α-Synuclein Complexes Visualized by “In Situ” Proximity Ligation Assay in Transgenic Mice Modelling Early Parkinson's Disease
por: Bellucci, Arianna, et al.
Publicado: (2012)

Correction to: Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data
por: Kareva, Irina, et al.
Publicado: (2021)

Correction: Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa
por: Harrison, Robert A., et al.
Publicado: (2020)

Correction to: miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson’s disease
por: Liu, Xiaoting, et al.
Publicado: (2019)

Correction: A genetic analysis of a Spanish population with early onset Parkinson’s disease
Publicado: (2021)

Correction: Biotinidase deficiency: Genotype-biochemical phenotype association in Brazilian patients
por: Borsatto, Taciane, et al.
Publicado: (2017)

Correction: The Economics of Reproducibility in Preclinical Research
Publicado: (2018)

Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity
por: Perez, Francisco A, et al.
Publicado: (2005)

Parkin deficiency exacerbates fasting-induced skeletal muscle wasting in mice
por: Peker, Nesibe, et al.
Publicado: (2022)

parkin counteracts symptoms in a Drosophila model of Parkinson's disease
por: Haywood, Annika FM, et al.
Publicado: (2004)

Parkinson’s disease-associated protein Parkin: an unusual player in cancer
por: Liu, Juan, et al.
Publicado: (2018)

Multitasking guardian of mitochondrial quality: Parkin function and Parkinson’s disease
por: Kamienieva, Iryna, et al.
Publicado: (2021)

Parkin as a Molecular Bridge Linking Alzheimer’s and Parkinson’s Diseases?
por: Checler, Frédéric, et al.
Publicado: (2022)

Is PARKIN parkinsonism a cancer predisposition syndrome?
por: Schüle, Birgitt, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1id4119tp720qp64uo27uo42na